SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
Open accessAbstract
Immune Response to a Third Dose of BNT162b2 A third dose of the BNT162b2 vaccine was administered to 23 volunteers 8 to 9 months after the second dose, and the immune response was assessed. Local r...
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 4 · Cited by 361
- Authors
- Falsey, A. R., Frenck, R. W., Walsh, E. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Bailey, R., Swanson, K. A., Xu, X., Koury, K., Kalina, W., Cooper, D., Zou, J., Xie, X., Xia, H., Türeci, Ö., Lagkadinou, E., Tompkins, K. R., Shi, P.-Y., Jansen, K. U., Şahin, U., Dormitzer, P. R., & Gruber, W. C.
- Affiliations
- University of Rochester (US)
- Cincinnati Children's Hospital Medical Center (US)
- Pfizer (United Kingdom) (GB)
- Pfizer (United States) (US)
- The University of Texas Medical Branch at Galveston (US)
- BioNTech (Germany) (DE)
- Corresponding author
- Kitchin, Nicholas
- ORCID
- Falsey, Ann R.
- Frenck, Robert W.
- Walsh, Edward E.
- Kitchin, Nicholas
- Absalon, Judith
- Gurtman, Alejandra
- Lockhart, Stephen
- Swanson, Kena A.
- Xu, Xia
- Cooper, David
- Zou, Jing
- Xie, Xuping
- Xia, Hongjie
- Türeci, Özlem
- Lagkadinou, Eleni
- Tompkins, Kristin R.
- Shi, Pei-Yong
- Jansen, Kathrin U.
- Şahin, Uğur
- Dormitzer, Philip R.
- Gruber, William C.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-10-21
- Volume
- 385
- Issue
- 17
- Pages
- 1627-1629
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC8461567
- OpenAlex
- W3200511289
- Cited by
- 361
- References
- 4
- Citations by year
- 2026: 6 · 2025: 22 · 2024: 32 · 2023: 61 · 2022: 201 · 2021: 38
- FWCI
- 26.45
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- New England Journal of Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- BNT162b2, third vaccine dose, immune response, booster vaccination, mRNA vaccines
- MeSH terms
- Immunogenicity, Vaccine, COVID-19, SARS-CoV-2, COVID-19 Vaccines, BNT162 Vaccine, Adolescent, Adult, Aged, Aged, 80 and over, Antibodies, Viral, Humans, Immunization, Secondary, Middle Aged, Young Adult, Antibodies, Neutralizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
